Picard Announces Appointment of Two New Members to its Board of Directors
TUCSON, Ariz., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard" or the "Company"), parent company of SynCardia Systems LLC, maker of the world's first U.S. and Canadian commercially-approved total artificial heart, today announced the appointment of two new members that will serve on its Board of Directors, Sam Van and George Ye. Both were appointed following the closing of the initial public offering and have deep leadership experience in complementary areas to advise the company in its next stage as a public company. "We are thrilled to welcome Sam and Geore to our Board," said Patrick NJ Schnegelsberg, Chief Executive Officer of Picard Medical, Inc. "Sam bri
